Navigation Links
OXiGENE Abstracts Published in ASCO Program

eve synergistic antitumor activity when administered concurrently. In animal studies, ZYBRESTAT has been shown to enhance the anti-tumor effects of several chemotherapeutic agents, several anti-angiogenic drugs, and radiation.

OXi4503 is a novel, second-generation vascular disrupting agent with potential intrinsic cytotoxicity exerted through an ortho-quinone metabolite. The drug candidate has demonstrated single-agent activity in human tumor xenograft models. Preclinical research with OXi4503 suggests that it not only shuts down tumor blood flow, but can also be metabolized into a compound which could assist with killing the remaining tumor cells at the periphery of the tumor by direct cytotoxic activity against tumor cells. In December 2004, the United Kingdom regulatory authorities accepted an application from our collaborators, Cancer Research UK, to initiate a dose-escalating Phase I clinical trial of OXi4503 in patients with advanced cancer. This trial is currently ongoing. In 2007, OXiGENE plans to initiate several preclinical studies to evaluate OXi4503 and possibly a Phase Ib clinical trial of OXi4503 in combination with an approved anti-angiogenic therapeutic.

About OXiGENE, Inc.

OXiGENE is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company's major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients.

Safe Harbor Statement

This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any or all of the forward-looking statements in this press release including the initiation of further clinical trials with
'"/>




Page: 1 2 3 4

Related medicine technology :

1. OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology
2. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
3. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
4. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
5. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
6. SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
9. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
10. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
11. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: OXiGENE Abstracts Published ASCO Program
(Date:5/20/2013)... , May 20, 2013  Medicare Part D ... overwhelmingly satisfied, citing lower costs, convenient access to ... survey from Hart Research Associates released today by ... 40% of Part D seniors (9.5 million) are ... "Seniors like the lower costs, pharmacy choices, ...
(Date:5/19/2013)... , May 20, 2013 Claret Medical, Inc. ... Nicolas Van Mieghem et al., Histopathology ... Published ahead of print in Circulation, May 7 th ... Medical Center, Rotterdam, the Netherlands and ... of the Cardiovascular Pathology Institute, Gaithersburg, Maryland.  ...
(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...
Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... N.J., Oct. 12 Schering-Plough Corporation (NYSE: SGP ) ... the 2009 third quarter on Thursday, Oct. 22, 2009. ... Schering-Plough will conduct a conference call to review results for ... CEO, and other members of management will host the conference ...
... , ANN ARBOR, Mich., Oct. 12 The University ... (®) from Thomson Reuters to provide physicians, nurses, and ... electronic drug dosing, interaction checking, and reference information. ... 575-bed academic medical center that specializes in heart disease, ...
Cached Medicine Technology:Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 3
(Date:5/20/2013)... 2013 According to a June 2009 ... medical malpractice amount to approximately $3.6 billion dollars per ... Healthcare Improvement estimated that there 15 million incidents of ... suggest that everyone who receives any form of medical ... malpractice. Merriam-Webster defines malpractice as “a dereliction of ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... Arlington, VA (PRWEB) May 20, 2013 ... Service Project , Who:    Sloan Gibson, President, ... Chwatsky, Vice President of Outreach Initiatives ... Monster, Sesame Street , Representatives from:, ... Senate ,          • ...
(Date:5/20/2013)... 2013 The American Society for Clinical ... Pink®, the organization that empowers young women to be proactive ... 2012. Thanks to its members, ASCP raised more than $6,000 ... in Relay for Life at the local level. When he ... to donate. “I was made aware of the opportunity when ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 For more ... have waged a battle against drug and alcohol abuse ... has released its first guide to help Italian speakers ... published by the European Monitoring Centre for Drugs and ... four have used cannabis in the last year. As ...
Breaking Medicine News(10 mins):Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 2Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 3Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2
... new study from Utrecht and Cambridge Universities has for ... under the tongue in volunteers negatively affects a person,s ... The findings are published this week in the journal ... In addition, the effects of testosterone administration are predicted ...
... Spanish . Researchers from the Hospital Virgen de ... identified the most frequent mutations in the gene KCNH2 in ... a disorder of cardiac ionic channels that approximately affects one ... episodes, which can trigger sudden death. This condition usually affects ...
... cancer in Europe in 2011 according to predictions from a ... today (Wednesday 9 February) [1]. The estimates, ... time in Europe a new mathematical model for predicting cancer ... both men and women when compared to 2007. But they ...
... a time when the effects of paediatric oncology research have ... is too low and dependent on short-term grants to be ... report supported by the EU-funded 7th Framework Programme project Eurocancercoms ... authors also looked at the citation impact of paediatric oncology ...
... CHICAGO Among patients with early-stage breast cancer that had ... that included lumpectomy and radiation therapy, women who just had ... which cancer is likely to spread from the primary tumor) ... extensive axillary lymph node dissection (surgery to remove lymph nodes ...
... common cause of death among patients with pneumonia, sepsis or ... damage often occurs suddenly and can cause life-threatening breathing problems ... Patients usually are put on ventilators to give their lungs ... can do but wait and hope for the best. ...
Cached Medicine News:Health News:Extra testosterone reduces your empathy 2Health News:Researchers identify the genotype of disorders causing cardiac sudden death syndrome 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Childhood cancer research in danger 2Health News:Childhood cancer research in danger 3Health News:Limited lymph node removal for certain breast cancer does not appear to result in poorer survival 2Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 2Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: